Pharmena S.A. (WSE:PHR)
Poland · Delayed Price · Currency is PLN 3.110
-0.050 (-1.58%)
Jul 24, 2026, 1:19 PM CET
Pharmena Market Cap
Pharmena has a market cap or net worth of 34.64 million as of July 24, 2026. Its market cap has decreased by -12.15% in one year.
Market Cap
34.64M
Enterprise Value
34.57M
Revenue
1.61M
Ranking
n/a
PE Ratio
n/a
Stock Price
3.11
ChartMarket Cap Chart
Since August 25, 2008, Pharmena's market cap has decreased from 171.99M to 34.64M, a decrease of -79.86%. That is a compound annual growth rate of -8.55%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 24, 2026 | 34.64M | 19.62% |
| Dec 30, 2025 | 28.96M | -32.11% |
| Dec 30, 2024 | 42.66M | -46.06% |
| Dec 29, 2023 | 79.08M | 26.79% |
| Dec 30, 2022 | 62.37M | -29.20% |
| Dec 30, 2021 | 88.10M | -10.89% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Bioceltix | 542.16M |
| Captor Therapeutics Spolka Akcyjna | 479.05M |
| Ryvu Therapeutics | 346.80M |
| BIOTON | 330.15M |
| Synthaverse | 208.37M |
| Poltreg | 138.45M |
| Molecure | 122.59M |
| Mabion | 119.12M |